Tag #Stock Market

Showing 829 to 840 of 940 results

dailymail.co.uk
🌐 75% Global Worthiness
News related image

Games Workshop to Join FTSE 100

Games Workshop, founded in 1975, is joining the FTSE 100 after its shares soared 43% this year and 2500% over the past decade, reaching a £4.7 billion valuation.

Progress

44% Bias Score

Decent Work and Economic Growth
forbes.com
🌐 75% Global Worthiness
News related image

Pfizer Stock Plunges 50% Amidst Falling Sales and Vaccine Concerns

Pfizer stock is down 50% since early 2022 to $26, driven by a 42% fall in 2023 sales to $58.5 billion following the Covid-19 pandemic and concerns over new leadership's stance on vaccines, despite efforts to cut costs and develop new drugs.

Progress

40% Bias Score

cnbc.com
🌐 75% Global Worthiness
News related image

Market Volatility: JetBlue and Salesforce Soar, While Chewy and Foot Locker Plunge

Midday trading saw mixed results, with JetBlue and Salesforce shares surging 8% due to positive financial reports, while Chewy and Foot Locker fell by almost 4% and over 6%, respectively, following disappointing earnings reports.

Progress

48% Bias Score

zeit.de
🌐 85% Global Worthiness
News related image

Delaware Judge Blocks Elon Musk's Tesla Compensation Package

A Delaware judge blocked Tesla CEO Elon Musk's multi-billion dollar compensation package, citing his undue influence on the 2018 stock distribution and lack of shareholder transparency regarding his relationships with Tesla board members; Tesla plans to appeal.

Progress

52% Bias Score

Reduced Inequality
cnbc.com
🌐 75% Global Worthiness
News related image

Market Consolidation Follows Record High; Amgen Removed from Bullpen

The S&P 500 consolidated on Tuesday after hitting a record high on Monday, influenced by overbought conditions and anticipation of key economic data. Amgen was removed from the CNBC Investing Club's Bullpen watchlist due to disappointing phase 2 trial results for its obesity drug, MariTide.

Progress

40% Bias Score

cnbc.com
🌐 65% Global Worthiness
News related image

HIMS Stock Rises Despite Volatility, Driven by Diverse Revenue Streams

Hims & Hers Health (HIMS) stock price rose from $23.50 in July to $32.50 currently, despite September's dip below $14; its compounded semaglutide injections, representing under 10% of revenue, contribute to volatility, while the company shows continued strength.

Progress

40% Bias Score

Good Health and Well-being
themarker.com
🌐 75% Global Worthiness
News related image

South Korea Political Crisis Shakes Asian Markets

Following South Korean President Yoon Suk-yeol's declaration and subsequent revocation of a state of emergency and martial law, Asian markets saw mixed reactions; Seoul's KOSPI fell 1.8%, while the South Korean won initially plunged to a two-year low versus the dollar before recovering slightly.

Progress

36% Bias Score

cnbc.com
🌐 75% Global Worthiness
News related image

AMD Stock Shows Signs of Recovery, Potential Mean-Reverting Rally

AMD stock, after a significant decline, shows signs of recovery as it holds above the $130 support level, suggesting a potential mean-reverting rally towards $170, based on technical analysis and two prior similar rallies totaling +76%.

Progress

48% Bias Score

Decent Work and Economic Growth
cnbc.com
🌐 65% Global Worthiness
News related image

Three Stocks Poised for Rally Based on "Golden Cross" Pattern

Disney, Cadence Design Systems, and Chevron show potential for future growth based on a bullish "golden cross" chart pattern and strong financial performance; analysts predict further price increases.

Progress

48% Bias Score

Decent Work and Economic Growth
cnbc.com
🌐 75% Global Worthiness
News related image

Intel Stock Plunges After CEO Ouster Amid Financial Struggles

Intel shares dropped over 5% after CEO Pat Gelsinger was ousted, marking the stock's worst day since early September and a more than 50% decline year-to-date, amid declining revenue, market share losses to competitors like Nvidia, and billions in quarterly foundry losses.

Progress

48% Bias Score

cincodias.elpais.com
🌐 65% Global Worthiness
News related image

Failed Buyouts Leave Grifols and Rovi to Pursue Independent Strategies

In 2024, proposed acquisitions of Grifols (valued at over €6.45 billion) and Rovi's CDMO business (valued at approximately €3 billion) failed due to valuation issues; both companies will continue operating independently.

Progress

36% Bias Score

cincodias.elpais.com
🌐 85% Global Worthiness
News related image

2025 Economic Forecast: Interest Rate Cuts and Strong Stock Market Predicted

Economic forecasts for 2025 predict interest rate cuts, no recession, strong stock market performance (except for tech giants), and a potentially weaker oil market; however, geopolitical risks remain significant.

Progress

32% Bias Score

Showing 829 to 840 of 940 results